Ikarian Capital, LLC Cullinan Oncology, Inc. Transaction History

Ikarian Capital, LLC

  • $573 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$22.56 - $29.68 $6.67 Million - $8.77 Million
-295,596 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$24.96 - $41.25 $7.35 Million - $12.2 Million
294,596 Added 29459.6%
295,596 $7.61 Million
Q1 2021

May 17, 2021
BUY
$28.0 - $53.42 $28,000 - $53,420
1,000 New
1,000 $42,000

Others Institutions Holding CGEM

# of Institutions
146
Shares Held
67.6M
Call Options Held
612K
Put Options Held
118K
View Full List

About Cullinan Oncology, Inc.

CGEM Quotes by TradingView
  • Ticker CGEM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,612,200
  • Market Cap $632M
  • Description
  • Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally available small molecule that is in a Phase I/IIa dose escalation and expansion trial for treating patients with ...
More about CGEM
Track This Portfolio

Track Ikarian Capital, LLC Portfolio

Follow Ikarian Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ikarian Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email